Issue 30, 2025, Issue in Progress

Correction: Hybrid thiazolyl–benzylidene–phenol metal complexes as novel chemotherapeutic agents with anti-topoisomerase I activity in human breast carcinoma: synthesis, in vitro and in silico studies

Abstract

Correction for ‘Hybrid thiazolyl–benzylidene–phenol metal complexes as novel chemotherapeutic agents with anti-topoisomerase I activity in human breast carcinoma: synthesis, in vitro and in silico studies’ by Ahmed M. Alharbi et al., RSC Adv., 2025, 15, 20552–20569, https://doi.org/10.1039/D5RA00889A.

Associated articles

Article information

Article type
Correction
Submitted
02 Jul 2025
Accepted
02 Jul 2025
First published
14 Jul 2025
This article is Open Access
Creative Commons BY license

RSC Adv., 2025,15, 24565-24565

Correction: Hybrid thiazolyl–benzylidene–phenol metal complexes as novel chemotherapeutic agents with anti-topoisomerase I activity in human breast carcinoma: synthesis, in vitro and in silico studies

A. M. Alharbi, M. Katary, K. M. Alshehri, B. H. Asghar, M. M. Omran, R. F. M. Elshaarawy, A. Mili, H. S. Hafez and R. Zakaria, RSC Adv., 2025, 15, 24565 DOI: 10.1039/D5RA90086G

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements